HLA-DR, toll-like receptor (TLR) 7, TLR9 and produce type I interferons. The role of human pDC in malaria remains poorly characterised. pDC activation and cytokine production were assessed in 59 malaria-naive volunteers during experimental infection with 150 or 1,800 P. falciparum-parasitized red blood cells. Using RNA sequencing, longitudinal changes in pDC gene expression were examined in five adults before and at peak-infection. pDC responsiveness to TLR7 and TLR9 stimulation was assessed in-vitro. Circulating pDC remained transcriptionally stable with gene expression altered for 8 genes (FDR < 0.07). There was no upregulation of co-stimulatory molecules CD86, CD80, CD40, and reduced surface expression of HLA-DR and CD123 (IL-3R-α). pDC loss from the circulation was associated with active caspase-3, suggesting pDC apoptosis during primary infection. pDC remained responsive to TLR stimulation, producing IFN-α and upregulating HLA-DR, CD86, CD123 at peak-infection. In clinical malaria, pDC retained HLA-DR but reduced CD123 expression compared to convalescence. These data demonstrate pDC retain function during a first blood-stage P. falciparum exposure despite submicroscopic parasitaemia downregulating HLA-DR. The lack of evident pDC activation in both early infection and malaria suggests little response of circulating pDC to infection.
Results
Circulating pDC gene expression is predominantly stable after primary pre-patent P. falciparum CHMI. We isolated blood pDC at >98% purity from five volunteers at baseline and at peak parasitaemia following intravenous infection with 1,800 pRBC (n = 5, median parasitaemia 4,754/mL [1, 929] ). Transcriptional gene expression changes were investigated by RNA sequencing as described in the methods. Globally, there were only modest changes (false detection rate, FDR < 0.07) in pDC gene expression. Eight gene transcripts had significantly decreased or increased gene expression (FDR < 0.07, Supplementary Figure 1 ), when baseline was compared to peak-infection. A summary of the top 10 genes that increased and top ten genes that decreased expression at peak-infection is presented in Table 1 . No P. falciparum RNA signal was detected (data not shown).
Circulating pDC of immature phenotype during early P. falciparum CHMI. To phenotypically characterise pDC during early P. falciparum infection we assessed maturation markers; CD86, CD40, CD80, HLA-A,B,C, HLA-DR and CD123 (IL-3Rα) expression on pDC before and at peak-infection for participants infected with either 150 pRBC or 1,800 pRBC. Mean parasitaemia was determined by PCR 29 . Participants administered 150 pRBCs reached peak parasitaemia on day 10 (n = 1, parasitaemia 12,750/mL), or day 11 (n = 11, median parasitaemia 2,380/mL [IQR 696-5085]), whereas participants administered 1,800 pRBCs reached peak parasitaemia on day 7 (n = 23, median parasitaemia 6,877/mL [IQR 4,759-12,813]) or day 8 (n = 24, median parasitaemia 4,970/mL [IQR 666-18,065]) ( Fig. 1A) . Circulating pDC were identified in whole blood as lineage marker negative (CD3, CD14, CD19, CD20, CD34 and CD56), HLA-DR + , CD11c − and CD123 + (Fig. 1B) . In fresh whole blood, less than 1% of pDC expressed CD86, CD40 or CD80 before infection or at peak parasitaemia (Fig. 1C ). pDC expression of CD123, the alpha subunit to the IL-3 receptor (IL-3Rα) 30 , frequently used to identify pDC subsets 31 , significantly reduced at peak parasitaemia and failed to recover by 24 hours after antimalarial treatment (Fig. 1D,E) . HLA-DR expression on pDC also reduced in both cohorts at peak parasitaemia ( Fig. 1D,E) . Additionally, HLA-A,B,C expression increased on pDC in the 1,800 pRBC cohort, although the increase was not statistically significant ( Fig. 1E ). In accordance with previous reports 32, 33 , pDC did not uptake FITC-dextran particulate antigen at baseline and this did not change with infection (data not shown). In clinical malaria, circulating pDC showed a similarly immature phenotype lacking upregulation of CD86 or HLA-DR and significantly reduced CD123 expression during acute disease compared to convalescence (Fig. 2 ).
Reduced circulating pDC number is associated with increased active caspase-3 expression. Circulating pDC numbers were determined longitudinally in both the 1,800 pRBC and 150 pRBC infection cohorts. pDC significantly declined at peak parasitaemia and continued to fall 24 hours after antimalarial drug treatment in the 1,800 pRBC infection cohort ( Fig. 3A, grey bars) . In the lower 150 pRBC cohort, pDC number fell significantly 24 hours pre and post peak parasitaemia ( Fig. 3A, white bars) . After antimalarial drug treatment, pDC numbers remained low at 48 and 72 hours ( Fig. 3A) . To determine if the loss of pDC was attributable to an increase in pDC apoptosis, circulating pDC were examined for the presence of the active form of caspase-3, a hallmark apoptosis marker. Caspase-3 is an executioner caspase, essential to both intrinsic and extrinsic apoptotic pathways 34 . There was no evidence of active caspase-3 in blood pDC following infection with 150 pRBC (n = 6; median 1% [IQR 1-3%] caspase-3, Fig. 3B ). In contrast, following 1,800 pRBC infection, we observed significantly increased active caspase-3 in pDC (n = 30; median 6.5% [IQR 2-18] caspase-3, Fig. 3B ).
Longitudinal changes in circulating pDC number and active caspase-3 expression were assessed in the 1,800 pRBC cohort, 48 hours before peak parasitaemia (day 6) to 48 hours after antimalarial treatment (day 10). As P. falciparum infection progressed, the number of circulating pDC declined, while pDC expressing caspase-3 increased (Fig. 1C ). Thus, we show for the first time that pDC are apoptotic during the higher dose P. falciparum infection.
Circulating pDC retain the ability to produce IFN-α and TNF during controlled P. falciparum infection. To assess pDC function during early P. falciparum infection we evaluated IFN-α, TNF, IL-10 and IL-12 cytokine production and maturation in response to TLR stimulation (n = 8, Fig. 4A ). pDC were identified as lineage − , HLA-DR + , CD11c − and CD123 (IL-3Rα) + (Fig. 4A ). At peak-infection, more pDC produced IFN-α in response to TLR7 (p = 0.02, Fig. 4B ) or TLR9 stimulation (p = 0.08, Fig. 4C ), when compared to baseline hence, the ability of pDC to produce IFN-α was not diminished during early P. falciparum blood-stage infection. IFN-α producing pDC always co-produced TNF ( Fig. 4A ) and infection did not change the proportion of pDC producing TNF alone ( Fig. 4B ,C). A comparison between cytokine MFI at peak parasitaemia and baseline (day 0) showed that TLR9-stimulated pDC expressed more IFN-α at peak-infection ( Fig. 4D ), whilst TNF production remained unchanged ( Fig. 4E ). No IL-10 or IL-12 production by pDC was detected. The same pattern of cytokine response (dual IFN-α/TNF and no IL-12 or IL-10) was observed when PBMC or fresh whole blood was used in the assay.
Circulating pDC significantly increased HLA-DR and CD123 surface expression upon TLR7 or TLR9 stimulation, at both baseline and peak parasitaemia (n = 8, Fig. 5A ,B). CD86 expression increased significantly following TLR7 stimulation at both baseline and peak parasitaemia, but not upon TLR9 stimulation with CpGA ( Fig. 5C ), as previously reported 35 . There was no significant change in pDC HLA-DR, CD86 or CD123 expression, either without stimulation (NIL) or following TLR7 or TLR9 stimulation, when baseline was compared to peak-infection in eight individuals.
Discussion
Here, we have shown pDC are not activated and remain functional during early P. falciparum infection. To the best of our knowledge, this is the first study to sequence RNA from highly purified pDC and compare gene expression before and at the peak of a primary P. falciparum CHMI. Unexpectedly, we found pDC gene expression to be largely stable in early sub-microscope infection. The observed minimal change in gene expression, together with an absence of activation/maturation phenotype by flow cytometry suggests, circulating blood pDC are not activated, yet remain functional during pre-patent blood-stage infection. While pDC gene expression was largely unchanged during early infection, a panel of eight genes significantly increased or decreased at peak-infection. The greatest increase in gene expression was seen in NLRC5 (NOD-like receptor (NLR) family, caspase recruitment (CARD) domain containing 5), an IFNγ-inducible transcriptional coactivator of MHC class I gene expression also known as CITA (MHC class I transactivator) 36 . NLRC5 is the master regulator of MHC class I gene expression and activates most of the key components of the MHC class I antigen presentation pathway 37 . In line with this, non-classical MHC class I HLA-F was in the top 10 upregulated genes in this study, although with a FDR > 0.07. Increased HLA class I protein expression was detected on the day after treatment, although not statistically significant. Together these findings suggest that pDC upregulate their MHC class I antigen presentation machinery during early P. falciparum infection, whether this leads to cross-presentation of parasite antigen to activate CD8 + T cells 38 or makes them targets for elimination by cytotoxic CD8 + T cells remains unclear. pDC have been suggested to act as a reservoir for Plasmodium in mice 39 ; however, we detected no Plasmodium RNA in isolated pDC to support this previous finding, suggesting that this does not occur in human pDC or that our methods lacked the sensitivity to identify Plasmodium RNA. Although still controversial, NLRC5 has also been reported to modulate type I IFN responses in various human and murine cell types 40 . Future studies into the effects of NLRC5 in malaria are warranted.
Amongst the downregulated genes was BAG3 (BCL2 associated athanogene gene 3), an anti-apoptotic co-chaperone protein 41 . Down-modulation of BAG3 in HIV-infected microglial cells results in accumulation of active caspase-3 42 . Here we show active caspase-3 detection by flow cytometry in pDC increased in the 1,800 pRBC cohort during early P. falciparum infection and was associated with pDC loss from the circulation. pDC loss equally occurred in the 150 pRBC cohort yet, this did not coincide with active caspase-3 detection. Whether this apparent lack of apoptosis in the 150 pRBC cohort is due to differing parasitaemia on the day of treatment or to the longer exposure to a very low parasite dose remains unclear. Very low doses of P. falciparum blood-stages have previously been shown to induce host immunity 43 . The reduction in blood pDC numbers during Plasmodium infection is in accordance with previous reports [18] [19] [20] [21] [22] [23] 27 . Additionally, we show for the first time, pDC reduce CD123, IL-3α receptor expression in P. falciparum CHMI and in acute falciparum malaria, suggesting this effect is independent of the route of infection. Whether this reduction impacts responsiveness to IL-3, a T cell derived glycoprotein that supports the viability and differentiation of haematopoietic cells 44 remains to be determined. Studies of isolated pDC from healthy adults report an increase in pDC CCR7 expression after in vitro stimulation with high concentration of P. falciparum schizont antigen 18 , suggesting pDC increase their ability to migrate to lymphoid organs following parasite contact. Whilst we did not detect any changes in CCR7 gene expression in this early infection, gene expression of CXCR4 was downregulated. pDC constitutively express CXCR4 on their surface which is required for their development 45 but also allows them to enter lymphoid tissues via high endothelial venules 46 . Downregulation of CXCR4 transcription may indicate less repopulation from the bone marrow, reduced ability to migrate to lymphoid tissue or indeed very early activation, as pDC downregulate CXCR4 gene expression following in vitro stimulation with Influenza virus 47 . In the P. yoelii model of severe malaria, pDC activation occurs very early during blood-stage infection 15, 17 and activated type I IFN producing pDC reside predominantly in the bone marrow and blood of P. yoelii YM infected mice 15 and not in the spleen as previously suggested 14, 48 . Conclusive evaluation of dendritic cell migration in human malaria will need to be addressed by researchers with access to Plasmodium infected human spleen tissue.
Blood pDC are important for maintaining a balance between immunity and immunopathology in viral infections 2 . Early production of type I IFNs by pDC are needed for containment of virues in systemic infections such as HSV-1 49 type I IFN production during infection is essential for the induction of protective immune responses 17 . In contrast, type I IFN production in P. berghei ANKA infection, leads to suppression of CD4 + T cell adaptive immune responses 51 , although the cellular sources of IFN-α were not identified. Whether pDC activation is desirable or detrimental in human malaria is still not clear.
Assessment of rare human dendritic cell subsets is difficult, and accessing longitudinal human malaria samples is even more challenging. To gain insights into human pDC function in malaria, we took advantage of the CHMI, which allowed longitudinal assessment of pDC function in malaira naive volunteers. Despite loss and apparent apoptosis, pDC retained the ability to respond to TLR stimulation. In contrast, during this same time frame of early pre-patent P. falciparum infection peripheral blood CD1c + mDC are dysfunctional and unable to upregulate HLA-DR following TLR stimulation 28 . Together, our studies suggest that DC subsets are differentially affected during P. falciparum blood-stage infection and these differences should be considered when evaluating dendritic cells in Plasmodium infection and malaria. Evidence of a functional human dendritic cell subset in P. falciparum infection is encouraging, as pDC may orchestrate downstream adaptive immune responses during infection.
Methods
P. falciparum CHMI. Written and informed consent was obtained from 59 volunteers who participated in a series of phase Ib clinical trials testing the efficacy of antimalarial drugs. Blood-stage P. falciparum infection was initiated by inoculation of trial parasite doses, 150 (n = 12) or 1,800 (n = 47) parasitised red blood cells (pRBC) as previously described 29 . Anticoagulated blood was collected for immunologic assessment at specific time points, before and during blood-stage infection. Antimalarial drugs were administered when volunteers reached a pre-determined parasitaemia of ≥1,000 parasites/mL (day 10 or 11; 150 pRBC and day 7 or 8; 1,800 pRBC) ( Fig. 1A) . Fresh whole blood or cryopreserved peripheral blood mononuclear cells (PBMCs) were used in flow cytometric assays. PBMCs were processed within 2 hours of collection. Acute malaria. The number and phenotype of pDC were assessed in cryopreserved PBMCs collected from adults with uncomplicated P. falciparum malaria (n = 10) as part of a pathophysiology study at Queen Elizabeth 1 and Kudat District Hospitals in Sabah, Malaysia 53 . PBMC samples were collected prior to commencing treatment, and again 14 to 28 days in a prospective fashion, after antimalarial drug treatment ( Table 2 ). PBMCs from family or friends of patients were evaluated as controls (n = 5). Written informed consent was obtained from participants and the study was approved by the Whole blood pDC and PBMC enumeration and activation. pDC were characterised as lineage (CD3, 14, 19, 20, 34, 56) − , HLA-DR + , CD11c − , CD123 + (Fig. 1B) . In brief, 200 µL of blood or 3 million PBMC were stained with surface antibodies; CD3 (HIT3a), CD14 (HCD14), CD19 (HIB19), CD20 (2H7), CD34 (561), CD56 (HCD56), HLA-DR (L243), CD11c (B-Ly6), CD123 (6H6), CD86 (2331, FUN-1), CD80 (2D-10), CD40 (5C3) and HLA-A,B,C (W6/32). All antibodies were purchased from BD Biosciences or Australian Biosearch, Biolegend. For whole blood, RBC were lysed with FACS lysing solution (BD, USA) and cells fixed with 1% (w/v) paraformaldehyde in phosphate-buffered saline. Absolute numbers of pDC were determined by adding automated lymphocyte and monocyte counts (10 9 cells/L), dividing the sum by 100, multiplying the percentage of pDC, and multiplying the product by 1,000 to give the cell count/µL. Apoptosis. Intracellular active caspase-3 was measured as previously described 54 . Briefly, 200 µL or 1,000 µL of blood was stained with surface antibodies, RBC were lysed with FACS lysing solution (BD, USA), cells were permeabilised using 1 × BD Perm/Wash ™ (BD, USA) and stained with active caspase-3 antibody (C92-605, BD USA).
FITC-dextran uptake. pDC phagocytosis was assessed by uptake of 1 mg/mL FITC-dextran (Sigma, USA) after 60 min at 37 °C, or on ice as a control, and expressed as delta median fluorescence intensity (ΔMFI) (i.e.
[MFI of cells at 37 °C]-[MFI control cells on ice]).
Intracellular cytokine staining. Cytokine production was assessed in PBMCs (2 million per well in RPMI 10% FCS (Invitrogen, USA)) or 1000 µL of WB stimulated with TLR agonists; TLR7: Imiquimod 2.5 µg/mL and TLR9: CpG ODN2216 50 ug/mL (Sigma-Aldrich, USA). Protein transport inhibitor (Brefeldin A, BD, USA) was added after 2 h at 37 °C, 5% CO 2 . At 6 h, cells were stained to identify pDC (including CD86 (IT2.2)), washed with 2% FCS/PBS, cells permeabilised with 1x Perm/Wash ™ and stained with intracellular anti-TNF-α (MAB11), IL-12/IL-23p40 (C11.5), IL-10 (JES3-9D7), and IFN-α (LT27:295). FACS data were acquired using a FACSCanto ™ II (BD, USA) or Gallios ™ (Beckman and Coulter, USA). Data were analysed using Kaluza ® 1.3 (Beckman Coulter, USA). pDC isolation and RNA Sequencing. RNA sequencing was performed on paired samples collected prior to and at peak-infection from five subjects experimentally infected with 1,800 P. falciparum pRBC. pDC were isolated from fresh PBMCs using the Human Diamond Plasmacytoid Dendritic Cell Isolation Kit (Miltenyi Biotec, Gladbach, Germany). In brief, pDC were enriched according to the manufacturer's instructions using CD304 (BDCA-4) conjugated microbeads and washed over MACs isolation columns. Purity of isolated pDC cell populations was checked using flow cytometry (day 0; median 99.3% [IQR 99.1-99.7%], day 7-8 median 99.6% [IQR 99.3-99.7%]) and the number of isolated pDC was estimated (day 0; median 14,336 cells [IQR 7,487-31,590 cells], day 7-8 median 38,491 cells [IQR 8,419-66,622 cells]. Isolated pDC were resuspended in RNAprotect (Qiagen, Australia) and stored immediately at −80 °C. RNA extraction and RNA-sequencing of five paired participant samples were conducted by Macrogen © (Seoul, Korea) using the Illumina TruSeq stranded mRNA LT sample kit and the HiSeq 2500 instrument. Transcriptome data were analysed using a modified version of an existing variant detection pipeline 55 consisting of software STAR aligner 56 , samtools 57 , HTSeq 58 , and DESeq2 59 . Reads were first aligned to human reference genome GRCh37 using STAR with the gene model set to gencode v19 annotation and quantmode set to TranscriptomeSAM. The alignment files were sorted with samtools and the resultant reads input to HTSeq to generate raw read counts using the union overlap resolution mode. Read counts were input to DESeq2 and a paired analysis performed for the five participants with baseline and peak parasitaemia data. Statistics. Statistical analyses were undertaken using GraphPad Prism 6 (Graphpad Software Inc., USA). The
Wilcoxon matched-pairs sign rank test was used to compare longitudinal data and a multiple comparisons test (1-way ANOVA) was used for comparison between no stimulation and TLR stimulation.
